Over 20% of people diagnosed with brain cancer survive longer than five years. But the NDIS may not recognise their need for support to live, work, learn and play.
Academic rigor, journalistic flair
Articles on Glioblastoma
Displaying all articles
Glioblastoma is the most aggressive type of brain cancer, causing significant decline in cognitive function. New research suggests a common anti-seizure drug could help control tumor growth.
Male and female tumors are different. Researchers are now hoping to exploit these sex-specific differences to treat brain cancer. This might improve survival for everyone.
When it comes to treating cancer, focus for decades has been on killing the fastest growing cells. New research finds that this approach may be too simple.
James Allison and Tasuku Honjo won the 2018 Nobel Prize in Physiology or Medicine for encouraging immune cells to attack cancer. See how their work has revolutionized cancer therapies and medicine.
John McCain was known as a tough fighter and patriot, refusing to yield to his captors’ torture while he was imprisoned as a POW. In the end, cancer claimed him. Researchers say progress is coming.
CAR-T is a powerful new immunotherapy for treating leukaemia. We need to build on it to attack other, harder-to-treat cancers.
There are several things we can do to speed up the development of new drugs, without putting patients at risk.
A diagnosis of glioblastoma did not keep John McCain from the Capitol to cast a crucial vote that could end Obamacare. His actions are a reminder that stats are one thing but human beings, another.
Glioblastoma is an aggressive form of brain cancer that has a very poor prognosis. Despite the current best therapies half its sufferers survive for 15 months and less than 5% are alive after 5 years.
Top contributors
-
Professor of Neurosurgery, University of Florida
-
Professor of Neuropathology, Queen Mary University of London
-
Research Fellow, European Cancer Stem Cell Research Institute, Cardiff University
-
Academic Clinical Fellow in Oncology, Queen Mary University of London
-
University of Florida
-
NHMRC Senior Research Fellow, Centre for Cancer Biology, University of South Australia
-
Senior Lecturer in Haematology, Immunolgy, Genetics and Evolution, University of Central Lancashire
-
Senior Lecturer, Flinders University
-
Research Associate, Casual Academic, PhD Candidate, Flinders University
-
Postdoctoral Fellow in Neurological Surgery, University of California, San Francisco
-
Professor, Pediatrics and Neuroscience, Washington University in St. Louis
-
Associate Professor of Neurological Surgery, University of California, San Francisco
